Displaying 1341 - 1360 of 1590
Obstetrics and Gynecology Medical Corporation of Napa Valley, a corporation et al.
A doctors’ group consisting of nearly every obstetrician and gynecologist with active medical staff privileges at the two general acute care hospitals in Napa County, California settled charges that they restrained price and other competition by engaging in illegal agreements to fix fees and other terms of dealing with health care insurance plans. According to the complaint issued with the consent order, the doctors refused to deal with the third party payers except on collectively determined terms. The consent order not only prevents the doctors from engaging in similar practices in the future but also requires the dissolution of the group.
Two Denver-area Physician Groups Agree To Settle FTC Charges of Fixing Fees
Prepared Statement of the Federal Trade Commission On Pharmaceutical Industry
Wrongful "Orange Book" Listing Raises Red Flag with FTC; Leads to Consent Order with Biovail Corp. Concerning its Drug Tiazac
The Antitrust Implications of "Clinical Integration:" An Analysis of FTC Staff's Advisory Opinion to MedSouth
Napa Valley OB/GYN Group Settles FTC Antitrust Charges
FTC Staff Opposes Alaska Physicians' Health Plan Legislation:
Staff Advisory Opinion:
FTC Agreement with American Home Products Corp. Would Protect Consumers from Anticompetitive Practices
Roche Holding Ltd, In the Matter of
Roche agreed to divest, certain assets in the U.S. and Canada to settle antitrust concerns stemming from its proposed acquisition of Corange Limited. The consent order permits the acquisition but requires the divestiture of Cardiac thrombolytic agents (drugs used to treat heart attack victims) and ongoing business assets relating to chemicals used to test for the presence of illegal or abused drugs.
FTC Staff Opposes Washington State Proposal to Allow Physician Collective Bargaining
FTC Staff Opposes Alaska Proposal to Allow Physician Collective Bargaining
Announced Actions for January 9, 2002
In re: Buspirone Antitrust Litigation MDL
In re: First Databank Antitrust Litigation
Non-profit Institutions Act Covers Pharmaceuticals Dispensed to Retired Employees, FTC Staff Advises
Hearst Corp. To Disgorge $19 Million and Divest Business to Facts and Comparisons to Settle FTC Complaint
Hearst Trust, The, The Hearst Corporation, and First DataBank, Inc.
The Commission negotiated an agreement with The Hearst Corporation (Hearst) to settle a permanent injunction action filed by the FTC alleging that Hearst failed to provide documents required by premerger notification law and then consummated a merger that monopolized the integrated drug information database market. Under the terms of the order, Hearst divested the Medi-Span business to Lippincott Williams & Wilkins, Inc. , a subsidiary of Wolters Kluwer, n.v., disgorged $19 million in profits, and to complied with certain other obligations.
Statement of Susan A. Creighton, Deputy Director, Bureau of Competition Regarding FTC Settlement with Hearst Corporation
Displaying 1341 - 1360 of 1590